John Renger

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Renger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by John Renger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024090830-renger-john-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 4 $0 4 Chief Scientific Officer 05 Aug 2024, 16:30
/report/000095017024012962-renger-john-2024-02-06 Cerevel Therapeutics Holdings, Inc. 06 Feb 2024 3 -$89,777 4 Chief Scientific Officer 08 Feb 2024, 19:19
/report/000095017024006704-renger-john-2024-01-19 Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 Chief Scientific Officer 23 Jan 2024, 17:50
/report/000089924323004366-renger-john-2023-02-06 Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 2 $0 4 Chief Scientific Officer 08 Feb 2023, 19:34
/report/000089924322034915-renger-john-2022-11-01 Cerevel Therapeutics Holdings, Inc. 01 Nov 2022 5 -$560,927 4 Chief Scientific Officer 03 Nov 2022, 16:28
/report/000089924322033167-renger-john-2022-10-04 Cerevel Therapeutics Holdings, Inc. 04 Oct 2022 5 -$560,922 4 Chief Scientific Officer 06 Oct 2022, 16:59
/report/000089924322028481-renger-john-2022-08-10 Cerevel Therapeutics Holdings, Inc. 10 Aug 2022 6 -$1,863,075 4 Chief Scientific Officer 12 Aug 2022, 16:15
/report/000089924322028190-renger-john-2022-08-05 Cerevel Therapeutics Holdings, Inc. 05 Aug 2022 6 -$922,500 4 Chief Scientific Officer 09 Aug 2022, 21:23
/report/000089924322026577-renger-john-2022-07-20 Cerevel Therapeutics Holdings, Inc. 20 Jul 2022 3 -$662,500 4 Chief Scientific Officer 22 Jul 2022, 16:15
/report/000089924322025685-renger-john-2022-07-05 Cerevel Therapeutics Holdings, Inc. 05 Jul 2022 6 -$694,545 4 Chief Scientific Officer 07 Jul 2022, 16:06
/report/000089924322014882-renger-john-2022-04-13 Cerevel Therapeutics Holdings, Inc. 13 Apr 2022 3 -$1,401,592 4 Chief Scientific Officer 15 Apr 2022, 16:19
/report/000089924322012940-renger-john-2022-03-29 Cerevel Therapeutics Holdings, Inc. 29 Mar 2022 3 -$315,000 4 Chief Scientific Officer 31 Mar 2022, 16:05
/report/000089924322011639-renger-john-2022-03-16 Cerevel Therapeutics Holdings, Inc. 16 Mar 2022 6 -$1,242,509 4 Chief Scientific Officer 18 Mar 2022, 19:56
/report/000089924322010697-renger-john-2022-03-09 Cerevel Therapeutics Holdings, Inc. 09 Mar 2022 4 -$895,000 4 Chief Scientific Officer 11 Mar 2022, 15:08
/report/000089924322009392-renger-john-2022-03-02 Cerevel Therapeutics Holdings, Inc. 02 Mar 2022 3 -$662,500 4 Chief Scientific Officer 04 Mar 2022, 15:12
/report/000089924322005941-renger-john-2022-02-09 Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 4 -$662,500 4 Chief Scientific Officer 11 Feb 2022, 17:46
/report/000089924321049933-renger-john-2021-12-23 Cerevel Therapeutics Holdings, Inc. 23 Dec 2021 6 -$315,027 4 Chief Scientific Officer 28 Dec 2021, 15:31
/report/000089924321049620-renger-john-2021-12-21 Cerevel Therapeutics Holdings, Inc. 21 Dec 2021 3 -$211,700 4 Chief Scientific Officer 23 Dec 2021, 16:14
/report/000089924321048894-renger-john-2021-12-15 Cerevel Therapeutics Holdings, Inc. 15 Dec 2021 9 -$1,031,248 4 Chief Scientific Officer 17 Dec 2021, 19:27
/report/000089924321044579-renger-john-2021-11-10 Cerevel Therapeutics Holdings, Inc. 10 Nov 2021 7 -$1,999,687 4 Chief Scientific Officer 15 Nov 2021, 15:18